Published in J Infect Dis on January 01, 1997
Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol (2001) 2.17
Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev (2003) 2.06
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs. J Virol (2005) 1.68
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection. Proc Natl Acad Sci U S A (1999) 1.54
Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2. J Virol (2000) 1.53
Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J Virol (2001) 1.32
HSV-2: in pursuit of a vaccine. J Clin Invest (2011) 1.29
Herpes simplex viruses: is a vaccine tenable? J Clin Invest (2002) 1.18
Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs. Vaccine (2005) 1.12
Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti Infect Ther (2009) 1.12
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PLoS One (2011) 1.10
Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates? Vaccine (2011) 1.07
New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines (2009) 1.07
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease. Elife (2015) 1.07
Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity. J Virol (2002) 1.06
Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread. J Virol (2012) 1.01
HSV Recombinant Vectors for Gene Therapy. Open Virol J (2010) 0.99
Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry. PLoS One (2010) 0.99
Herpes simplex virus type 2 vaccines: new ground for optimism? Clin Diagn Lab Immunol (2004) 0.94
Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells. Mol Ther (2011) 0.90
Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J Virol (2006) 0.90
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs. BMC Microbiol (2010) 0.85
Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1. J Invest Dermatol (2009) 0.85
High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection. J Invest Dermatol (2008) 0.85
Two-color fluorescence analysis of individual virions determines the distribution of the copy number of proteins in herpes simplex virus particles. Biophys J (2007) 0.84
The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice. J Virol (2004) 0.84
Inhibition of the host translation shutoff response by herpes simplex virus 1 triggers nuclear envelope-derived autophagy. J Virol (2013) 0.81
Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia. Can J Infect Dis (2003) 0.81
A single gD glycoprotein can mediate infection by Herpes simplex virus. J Am Chem Soc (2013) 0.81
Production of high titre disabled infectious single cycle (DISC) HSV from a microcarrier culture. Cytotechnology (1999) 0.77
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1. J Virol (2004) 0.77
Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert Rev Vaccines (2014) 0.76
Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus. Curr Pharm Des (2007) 0.76
Towards an effective genital herpes vaccine: past lessons and future prospects. Future Virol (2007) 0.76
Control of STDs--the role of prophylactic vaccines against herpes simplex virus. Sex Transm Infect (1998) 0.75
Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine. Clin Exp Vaccine Res (2015) 0.75
Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs. Front Immunol (2016) 0.75
Positional cloning of the Werner's syndrome gene. Science (1996) 10.98
Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell (1989) 6.62
Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest (1970) 6.44
Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) (1966) 6.15
Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care. BMJ (2000) 6.14
Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol (2001) 6.05
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
The cohort effect and Helicobacter pylori. J Infect Dis (1993) 4.28
The Werner syndrome protein is a DNA helicase. Nat Genet (1997) 4.03
Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns. Obes Rev (2005) 3.97
The cornea is not a piece of plastic. J Refract Surg (2000) 3.72
An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV. EMBO J (1987) 3.66
Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc Natl Acad Sci U S A (1989) 3.55
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Environment. Can we defy nature's end? Science (2001) 3.14
Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces. Neuron (2001) 2.92
Vaccination prevents latent HSV1 infection of mouse brain. Neurobiol Aging (2001) 2.85
Disparities in cancer diagnosis and survival. Cancer (2001) 2.81
Ribosomal pausing during translation of an RNA pseudoknot. Mol Cell Biol (1993) 2.81
The mutation rate and variability of eukaryotic viruses: an analytical review. J Gen Virol (1987) 2.77
Measuring performance to drive improvement: development of a clinical indicator set for general medicine. Intern Med J (2009) 2.66
Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser (1978) 2.66
Epidural abscess complicating insertion of epidural catheters. Br J Anaesth (2002) 2.65
Mutational analysis of the "slippery-sequence" component of a coronavirus ribosomal frameshifting signal. J Mol Biol (1992) 2.64
Polypeptides specified by the influenza virus genoma. 2. Assignement of protein coding functions to individual genome segments by in vitro translation. Virology (1977) 2.64
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet (1996) 2.59
Mutational analysis of the RNA pseudoknot component of a coronavirus ribosomal frameshifting signal. J Mol Biol (1991) 2.49
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet (2001) 2.40
Viral hepatitis. A staff hazard in dialysis units. Lancet (1967) 2.38
Anopheles gambiae pilot gene discovery project: identification of mosquito innate immunity genes from expressed sequence tags generated from immune-competent cell lines. Proc Natl Acad Sci U S A (2000) 2.38
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc Natl Acad Sci U S A (1979) 2.32
Retinal thickness measurements from optical coherence tomography using a Markov boundary model. IEEE Trans Med Imaging (2001) 2.29
Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med (1999) 2.25
Multidimensional Treatment Foster Care for Adolescents in English care: randomised trial and observational cohort evaluation. Br J Psychiatry (2013) 2.16
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14
Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet (1987) 2.12
Survey of general practitioners' treatment of the discharging ear. Br Med J (Clin Res Ed) (1988) 2.02
Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp Cell Res (1992) 1.98
Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell (1997) 1.93
A six-center international study of treatment outcome in patients with clefts of the lip and palate: Part 5. General discussion and conclusions. Cleft Palate Craniofac J (1992) 1.92
Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes. Virology (1989) 1.92
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol (2001) 1.91
Ilizarov principles of deformity correction. Ann R Coll Surg Engl (2010) 1.88
An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet (1997) 1.88
Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet Cell Genet (1981) 1.85
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Extraintestinal salmonellosis. Epidemiol Infect (1988) 1.82
Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci (1997) 1.80
Rheumatology training in the United Kingdom: the trainees' perspective. Rheumatology (Oxford) (2004) 1.80
Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am J Pathol (1974) 1.78
Dimethyl sulfoxide enhances polyethylene glycol-mediated somatic cell fusion. Somatic Cell Genet (1976) 1.78
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol (2001) 1.76
Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet (1993) 1.76
Day hospital versus admission for acute psychiatric disorders. Cochrane Database Syst Rev (2003) 1.75
Corridor consultations and the medical microbiological record: is patient safety at risk? J Clin Pathol (2003) 1.74
Early congenital syphilis still occurs. Arch Dis Child (1985) 1.72
Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci (2000) 1.71
Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.70
A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) (1975) 1.67
Leucocyte esterase-nitrite screening method for pyuria and bacteriuria. J Clin Pathol (1985) 1.67
Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem (1996) 1.66
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
Nucleotide sequence of fowl plague virus RNA segment 7. J Gen Virol (1982) 1.65
Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann Rheum Dis (2009) 1.63
Patient satisfaction with out of hours primary medical care. Qual Health Care (2001) 1.63
School smoking policies and smoking prevalence among adolescents: multilevel analysis of cross-sectional data from Wales. Tob Control (2001) 1.62
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Longitudinal study of Toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect (1992) 1.60
The raw oyster consumer--a risk taker? Use of the Behavioral Risk Factor Surveillance System. Epidemiology (1991) 1.60
Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J Allergy Clin Immunol (2000) 1.60
Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. BMJ (2011) 1.55
Community attitudes to smoking in restaurants. Med J Aust (1992) 1.54
A review of the management of open fractures of the tibia and femur. J Bone Joint Surg Br (2006) 1.54
Endoscopic surgery in weightlessness: the investigation of basic principles for surgery in space. Surg Endosc (2001) 1.53
Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am J Hum Genet (1997) 1.52
ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess (2009) 1.51
Feminist fallacies: a reply to Hakim on women's employment. Br J Sociol (1996) 1.49
Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) (1984) 1.49
Increased susceptibility of Down's syndrome fibroblasts to transformation by SV40. Proc Soc Exp Biol Med (1967) 1.49
Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport (1996) 1.48
Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48
Symposium on in vitro studies related to atherogenesis. Life histories of hyperplastoid cell lines from aorta and skin. Exp Mol Pathol (1973) 1.47
Systematic assessments of need and care planning in severe mental illness: cluster randomised controlled trial. Br J Psychiatry (2004) 1.47
Look-back investigation after human immunodeficiency virus seroconversion in a pediatric dentist. J Infect Dis (1994) 1.46
Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun (1997) 1.45
Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. Proc Natl Acad Sci U S A (1974) 1.45
Comparison of computational analysis with clinical measurement of stresses on below-knee residual limb in a prosthetic socket. Med Eng Phys (2000) 1.45
Variegated translocation mosaicism in human skin fibroblast cultures. Cytogenet Cell Genet (1975) 1.45
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Association of the infectious bronchitis virus 3c protein with the virion envelope. Virology (1991) 1.44
Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Am J Obstet Gynecol (1995) 1.44
Influenza vaccination in old age. Age Ageing (2001) 1.44
Exposure to teachers smoking and adolescent smoking behaviour: analysis of cross sectional data from Denmark. Tob Control (2002) 1.44
Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet (1996) 1.43
Workload and stress in consultant medical microbiologists and virologists: a questionnaire survey. J Clin Pathol (2002) 1.42